Related Experiment Video
Updated: Feb 6, 2026

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
IMMUNOTHERAPY OF BLADDER CANCER. BCG VACCINE: PRINCIPLES OF ACTION, EFFICACY AND SAFETY
Abstract:
Data on the principles of BCG vaccine action on the cancer of bladder are presented. Probable targets for BCG vaccine are estimated. Efficacy of BCG vaccine in non-muscle invasive cancer of bladder is analyzed. Side effects of BCG vaccine are examined. Possibilities of evaluating BCG vaccine usage at low (sub-therapeutical) doses are discussed. Various approaches to reducing the resistance of bladder cancer with respect to BCG vaccine are considered. The perspectives of bladder cancer immunotherapy are outlined.
Insights
The Bacillus Calmette-Guérin (BCG) vaccine shows efficacy in treating non-muscle invasive bladder cancer by stimulating an immune response. Research explores BCG
Area of Science:
- Immunology
- Oncology
- Urology
Background:
- Bladder cancer is a significant health concern, particularly non-muscle invasive types.
- Bacillus Calmette-Guérin (BCG) is an established immunotherapy for bladder cancer.
- Understanding BCG's mechanism and optimizing its use is crucial.
Purpose of the Study:
- To present data on BCG vaccine's action principles in bladder cancer.
- To estimate probable BCG vaccine targets.
- To analyze BCG efficacy, side effects, and resistance in bladder cancer treatment.
Main Methods:
- Review of BCG vaccine action mechanisms.
- Analysis of clinical data on BCG efficacy and side effects.
- Exploration of strategies to overcome BCG resistance.
Main Results:
- BCG vaccine demonstrates efficacy in non-muscle invasive bladder cancer.
- Potential targets for BCG action are identified.
- Side effects and resistance mechanisms are examined.
Conclusions:
- BCG immunotherapy is a key treatment for bladder cancer.
- Further research into optimizing BCG dosage and overcoming resistance is warranted.
- Future perspectives in bladder cancer immunotherapy are outlined.
Related Concept Videos
Principles of Drug Action
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Vaccinations
Tumor Immunotherapy
Survey Safety
The Uncertainty Principle

